Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A pioneering new charity dedicated to helping young people at risk of infertility has been set up by specialists from the Nuffield Department of Obstetrics & Gynaecology, the Institute of Research Studies at the University of Oxford, and the Oxford University Hospitals NHS Foundation Trust.

Sperm and egg © Sebastian Kaulitzki - Shutterstock
Sperm and egg

Image courtesy of Shutterstock

Ten young people under the age of 25 are diagnosed with cancer every day. Eight will be cured; one of these eight will become infertile as a result of their treatment and will not be able to have their own children.

The Future Fertility Trust can help these young people by providing expert care and support to enable them to access the best possible fertility advice and treatment to help them preserve their fertility.

Read more (Nuffield Department of Obstetrics & Gynaecology website)

Similar stories

Oxford vaccine reaches one billion doses released

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.

Research programme tackling COVID-19 variants of concern receives funding boost

A gift from the Red Avenue Foundation will enable the expansion of a major research programme aimed at rapidly identifying and interrogating emerging COVID-19 variants.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.